|
Volumn 38, Issue 1, 2010, Pages 338-
|
Corticosteroids and the original vasopressin and septic shock trial subgroups
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
NORADRENALIN;
VASOPRESSIN;
PLACEBO;
VASOPRESSIN DERIVATIVE;
CLINICAL PRACTICE;
DISEASE SEVERITY;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
SEPTIC SHOCK;
CIRCULATION;
HEART ARREST;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG COMBINATION;
DRUG INTERACTION;
FEMALE;
HUMAN;
INTENSIVE CARE;
INTENSIVE CARE UNIT;
MALE;
METHODOLOGY;
NOTE;
PROGNOSIS;
RISK ASSESSMENT;
SURVIVAL;
ADRENAL CORTEX HORMONES;
CLINICAL TRIALS AS TOPIC;
CRITICAL CARE;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INTENSIVE CARE UNITS;
MALE;
PROGNOSIS;
RISK ASSESSMENT;
SHOCK, SEPTIC;
SURVIVAL ANALYSIS;
VASOPRESSINS;
|
EID: 74049102912
PISSN: 00903493
EISSN: 15300293
Source Type: Journal
DOI: 10.1097/CCM.0b013e3181bc7ab8 Document Type: Letter |
Times cited : (1)
|
References (4)
|